OTCQB Certification

I, Nicholas Sosiak, Chief Financial Officer of Cannara Biotech Inc. ("the Company"), certify that:

1. The Company is registered or required to file periodic reporting with the SEC or is exempt from SEC registration as indicated below (mark the box below that applies with an "X"):

  • [] Company is registered under Section 12(g) of the Exchange Act

  • [] Company is relying on Exchange Act Rule 12g3-2(b)

  • [] Company is a bank that reports to a Bank Regulator under Section 12(i) of the Exchange Act

  • [] Company is a bank that is non-SEC reporting but is current in its reporting to a Banking Regulator

[] [] [] []

Company is reporting under Section 15(d) of the Exchange Act.

Company is reporting under the Alternative Reporting Company Disclosure Guidelines Company is reporting under Regulation A (Tier 2)

Other (describe)

2.

The Company is current in its reporting obligations as of the most recent fiscal year end and any subsequent quarters, and such information has been posted either on the SEC's EDGAR system or the OTC Disclosure & News Service, as applicable.

3. The company is duly organized, validly existing and in good standing under the laws of British Columbia, Canada in which the Company is organized or does business.

4. The share information below is for the primary OTCQB traded security as of the latest practicable date:

Trading Symbol

LOVFF

The data in this chart is as of:

January 11, 2022

Shares Authorized

(A)

unlimited

Total Shares Outstanding

(B)

876,481,321

Number of Restricted Shares1

(C)

47,525,392

Unrestricted Shares Held by Officers, Directors, 10% Control Persons & Affiliates

(D)

362,642,282

Public Float: Subtract Lines C and D from Line B

(E)

466,313,647

% Public Float: Line E Divided by Line B (as a %)2

(F)

53.2%

Number of Beneficial Shareholders of at least 100 shares3

(G)

6,525

1 Restricted Shares means securities that are subject to resale restrictions for any reason. Your transfer agent should be able to provide the total number of restricted securities.

2 Public Float means the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "10 percent Control Person"), or any Affiliates thereof, or any Family Members of officers, directors, and control persons. Family Member shall mean a Person's spouse, parents, children, and siblings, whether by blood, marriage or adoption, or anyone residing in such Person's home. OTCQB traded securities are required to have a freely traded public float of at least 10% of the shares outstanding unless an exemption applies.

3 Beneficial Shareholder means any person who, directly or indirectly has or shares voting power of such security or investment power, which includes the power to dispose, or to direct the disposition of, such security. OTCQB traded securities are required to have at least 50 beneficial shareholders unless an exemption applies.

  • 5. Convertible Debt:

    The following is a complete list of all promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities that were issued or outstanding at any time during the last complete fiscal year and any interim period between the last fiscal year end and the date of this OTCQB Certification:

    [] Check this box if there were no promissory notes, convertible notes, or other convertible debt arrangements issued or outstanding at any point during this time period.

    Date of

    Note Issuance

    Principal Amount at Issuance

    ($)

    Outstanding Balance ($)4

    Maturity

    Date

    Conversion Terms

    (e.g., pricing mechanism for determining conversion of instrument to shares)

    # Shares Converted to Date

    # of

    Potential Shares to be Issued Upon Conversion5

    Name of Noteholder (entities must have individual with voting / investment control disclosed).6

    Reason for Issuance (e.g., Loan, Services, etc.)

    June 21, 2021

    5,700,000

    5,700,000

    June 21, 2024

    Conversion at $0.18 per shares

    -

    59,444,444 common shares upon conversion

    Olymbec Investment Inc., owned at 50% by Derek Stern Familty Trust and 50% by Richard Stern Family Trust

    Loan

    Total Outstanding

    5,700,000

    Total Shares:

    -

    59,444,444

    Balance:

    Use the space below to provide any additional details, including footnotes to the table above:

  • 6. The following is a complete list of any law firm(s) and attorney(s) that acted as the Company's primary legal counsel in preparing its most recent annual report. Include the firm and attorney(s) name if outside counsel, or name and title if internal counsel. (If no attorney assisted in putting together the disclosure, identify the person(s) who prepared the disclosure and their relationship to the company.) Please also identify any other attorney, if different than the primary legal counsel, that assisted the company during the prior fiscal year on any matter including but not limited to, preparation of disclosure, press releases, consulting services, corporate action or merger assistance, etc.

    Brian Sherman, Cannara Biotech Inc.'s internal general and VP legal affairs

    Dentons Canada S.E.N.C.R.L, Charles Spector

  • 4 The Outstanding Balance is to include accrued interest.

  • 5 The total number of shares that can be issued upon full conversion of the Outstanding Balance. The number should not factor any "blockers" or limitations on the percentage of outstanding shares that can be owned by the Noteholder at a particular time. For purposes of this calculation, please use the current market pricing (e.g. most recent closing price, bid, etc.) of the security if conversion is based on a variable market rate.

6 International Reporting Companies may elect not to disclose the names of noteholders who are non-affiliates of the company. "Affiliate" is a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, an officer, a director, or a shareholder beneficially owning 10 percent or more of the Company's outstanding shares.

  • 7. The following is a complete list of third-party providers, including firm names and addresses, and primary contact names, engaged by the Company, its officers, directors or controlling shareholders, at any time during the last complete fiscal year and any interim period between the last fiscal year end and the date of this OTCQB Certification, to provide investor relations services, public relations services, marketing, brand awareness, consulting, stock promotion, or any other related services to the Company. Please describe the services provided by each third-party provider listed below. If none, please state "None".

    Investor relations services:

    David Kaiser - Kaiser & Partners Inc., 34 King Street East, suite 400, Toronto, Ontario M5C 2X8

    Sean Debotte - Independent Trading Group (ITG) Inc., 370 King Street West, suite 701, Toronto, Ontario M5V 1J9 Mike Polonsky - Loderock Advisors Inc., One Toronto Street, suite 202, Toronto, Ontario M5C 2V6

    Phil Carlson- KCSA Strategic Communications, 420 5th avenue, New York, NY 10018

  • 8. Officers, Directors and 5% Control Persons:

    The following is a complete list of Officers, Directors and 5% Control Persons (control persons are beneficial owners of five percent (5%) or more of any class of the issuer's equity securities), including name, address, and number of shares owned. Preferred shares, options, warrants that can be converted into common shares within the next 60 days should be included in the shareholdings listed below. If any of the beneficial shareholders are corporate entities, provide the name and address of the person(s) owning or controlling such corporate entities.

Name (First, Last)

City and State

(and Country if outside US)

Number of Shares Owned (list common, preferred, warrants and options separately)

Percentage of Class of

Shares Owned

Javaa Private Equity Inc. (controlled by Zohar Krivorot)

8000 Decarie Boulevard, suite 460

Montreal, Quebec H4P 2S4 Canada

shares: 242,167,820

27.63%

Zohar Krivorot

21 Croissant Applewood Hampstead, Quebec H3X 3B6

Canada

Options: 6,000,001 (5,375,000 vested)

-

Derek Stern

21 Lyncroft road Hampstead, Quebec H3X 3E3

Canada

Options: 100,000

-

Olymbec Investments Inc. (50% owned by Derek Stern

333 Decarie Boulevard 5th floor

Ville Saint-Laurent, Quebec H4N 3M9

Canada

shares: 163,650,184

18.67%

Jack Kay

23 Bryson Drive Richmond Hill, Ontario L4C 6E2

Canada

shares: 2,190,000 options: 150,000

0.25%

Mary Durocher

350 County road 27 South Woodslee, Ontario N0R 1V0

Canada

options: 200,000

-

Donald Olds

4139 Hampton avenue Montreal, Quebec H4A 2L1 Canada

shares: 489,220 options: 375,000

0.06%

Nicholas Sosiak

986 rue des fuchias Laval, Quebec

shares: 1,197,950 options: 6,000,000

0.14%

H7Y 0B4 Canada

(1,395,840 vested)

Avi Krivorot

5897 Beethoven Avenue Côte-St-Luc, Quebec H4W 3B5

Canada

shares: 472,500 Options: 300,000 (37,500 vested)

0.05%

Use the space below to provide any additional details, including conversion terms of any class of the issuer's equity securities:

9. Certification:

Date: January 11, 2022

Name of Certifying CEO or CFO: Nicholas Sosiak

Title: Chief Financial Officer

Signature: /s/ Nicholas Sosiak

(Digital Signatures should appear as "/s/ [OFFICER NAME]")

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Cannara Biotech Inc. published this content on 06 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 April 2022 16:01:10 UTC.